Precision medicine in diagnosis, prognosis, and disease monitoring of bone and soft tissue sarcomas using liquid biopsy: a systematic review
Top Cited Papers
Open Access
- 11 January 2025
- journal article
- review article
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 145 (1) , 1-23
Abstract
Introduction: Liquid biopsy as a non-invasive method to investigate cancer biology and monitor residual disease has gained significance in clinical practice over the years. Whilst its applicability in carcinomas is well established, the low incidence and heterogeneity of bone and soft tissue sarcomas explains the less well-established knowledge considering liquid biopsy in these highly malignant mesenchymal neoplasms. Materials and methods: A systematic literature review adhering to the PRISMA guidelines initially identified 920 studies, of whom 68 original articles could be finally included, all dealing with clinical applicability of liquid biopsy in sarcoma. Studies were discussed within two main chapters, i.e. translocation-associated and complex-karyotype sarcomas. Results: Overall, data on clinical applicability of liquid biopsy in 2636 patients with > 10 different entities of bone and soft tissue sarcomas could be summarised. The five most frequent tumour entities included osteosarcoma (n = 602), Ewing sarcoma (n = 384), gastrointestinal stromal tumour (GIST; n = 203), rhabdomyosarcoma (n = 193), and leiomyosarcoma (n = 145). Of 11 liquid biopsy analytes, largest evidence was present for ctDNA and cfDNA, investigated in 26 and 18 studies, respectively. Conclusions: This systematic literature review provides an extensive up-to-date overview about the current and potential future uses of different liquid biopsy modalities as diagnostic, prognostic, and disease monitoring markers in sarcoma.Keywords
Funding Information
- Medical University of Graz
This publication has 85 references indexed in Scilit:
- Circulating cell free DNA: Preanalytical considerationsClinica Chimica Acta, 2013
- Cell-free Circulating Mitochondrial DNA in the Serum: A Potential Non-invasive Biomarker for Ewing's SarcomaArchives of Medical Research, 2012
- Circulating tumour cells in cancer patients: challenges and perspectivesTrends in Molecular Medicine, 2010
- Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumorsMolecular Cancer, 2009
- Molecular pathology of sarcomas: concepts and clinical implicationsVirchows Archiv, 2009
- Characteristic sequence motifs located at the genomic breakpoints of the translocation t(12;16) and t(12;22) in myxoid liposarcomaPathology, 2008
- Biology of EWS/ETS fusions in Ewing's family tumorsOncogene, 2001
- Characterization of chromosome aberrations associated with soft‐tissue leiomyosarcomas by twenty‐four‐color karyotyping and comparative genomic hybridization analysisGenes, Chromosomes and Cancer, 2001
- Detection of tumour cells in peripheral blood and bone marrow from ewing tumour patients by rt‐pcrInternational Journal of Cancer, 1995
- Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcomaNature Genetics, 1993